$INGN News

Inogen, Inc. Q1 2026 Earnings Call Summary

Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript

Inogen Q1 Earnings Call Highlights

Inogen (NASDAQ:INGN) Q1 2026 Earnings: Revenue Beat Masks Guidance Miss, Stock Dips

Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates

Inogen Announces First Quarter 2026 Financial Results

Inogen, Inc. 2026 Q1 - Results - Earnings Call Presentation

Inogen Affirms FY2026 Sales Guidance of $366.000M-$373.000M vs $369.267M Est

Inogen Sees Q2 Sales $94.000M-$97.000M vs $97.250M Est

Inogen Q1 Adj. EPS $(0.14) Beats $(0.28) Estimate, Sales $85.109M Beat $82.350M Estimate

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

We're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn Rate

Inogen to Report First Quarter 2026 Financial Results on May 7, 2026

Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates

Inogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask Push

Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference

Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inogen Appoints Jason Richardson As CFO, Effective April 6, 2026

Inogen Appoints Jason Richardson As CFO, Effective April 6, 2026

Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound?